Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $130.39 in the prior trading day, Inspire Medical Systems Inc (NYSE: INSP) closed at $127.33, down -2.35%. In other words, the price has decreased by -$2.35 from its previous closing price. On the day, 1.42 million shares were traded. INSP stock price reached its highest trading level at $134.3 during the session, while it also had its lowest trading level at $126.7964.
Ratios:
Our goal is to gain a better understanding of INSP by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.47 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 37.44. For the most recent quarter (mrq), Quick Ratio is recorded 4.01 and its Current Ratio is at 5.29. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
On November 25, 2025, Wolfe Research Upgraded its rating to Outperform which previously was Peer Perform but kept the price unchanged to $180.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 20 ’25 when Curet Myriam bought 4 shares for $163.84 per share. The transaction valued at 655 led to the insider holds 3,370 shares of the business.
Curet Myriam bought 1 shares of INSP for $148 on Apr 07 ’25. The Director now owns 3,371 shares after completing the transaction at $148.26 per share. On Aug 08 ’25, another insider, Curet Myriam, who serves as the Director of the company, sold 4 shares for $77.28 each. As a result, the insider received 309 and left with 3,365 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSP now has a Market Capitalization of 3765697792 and an Enterprise Value of 3409739776. As of this moment, Inspire’s Price-to-Earnings (P/E) ratio for their current fiscal year is 87.33, and their Forward P/E ratio for the next fiscal year is 72.76. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 6.58. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.19 while its Price-to-Book (P/B) ratio in mrq is 5.55. Its current Enterprise Value per Revenue stands at 3.863 whereas that against EBITDA is 69.107.
Stock Price History:
The Beta on a monthly basis for INSP is 0.60, which has changed by -0.33943766 over the last 52 weeks, in comparison to a change of 0.12934029 over the same period for the S&P500. Over the past 52 weeks, INSP has reached a high of $216.01, while it has fallen to a 52-week low of $70.77. The 50-Day Moving Average of the stock is 54.22%, while the 200-Day Moving Average is calculated to be 3.36%.
Shares Statistics:
The stock has traded on average 1.22M shares per day over the past 3-months and 1840250 shares per day over the last 10 days, according to various share statistics. A total of 29.05M shares are outstanding, with a floating share count of 27.68M. Insiders hold about 4.73% of the company’s shares, while institutions hold 104.47% stake in the company. Shares short for INSP as of 1763078400 were 3671015 with a Short Ratio of 3.00, compared to 1760486400 on 2830111. Therefore, it implies a Short% of Shares Outstanding of 3671015 and a Short% of Float of 17.07.
Earnings Estimates
Inspire Medical Systems Inc (INSP) is presently subject to a detailed evaluation by 13.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $0.15, with high estimates of $0.41 and low estimates of -$0.22.
Analysts are recommending an EPS of between $1.65 and $0.99 for the fiscal current year, implying an average EPS of $1.51. EPS for the following year is $1.72, with 13.0 analysts recommending between $2.45 and $1.31.
Revenue Estimates
14 analysts predict $262.46M in revenue for. The current quarter. It ranges from a high estimate of $263.1M to a low estimate of $262M. As of. The current estimate, Inspire Medical Systems Inc’s year-ago sales were $239.72MFor the next quarter, 14 analysts are estimating revenue of $213.4M. There is a high estimate of $223.4M for the next quarter, whereas the lowest estimate is $204.21M.
A total of 17 analysts have provided revenue estimates for INSP’s current fiscal year. The highest revenue estimate was $908.29M, while the lowest revenue estimate was $900M, resulting in an average revenue estimate of $905.04M. In the same quarter a year ago, actual revenue was $802.8MBased on 17 analysts’ estimates, the company’s revenue will be $1B in the next fiscal year. The high estimate is $1.01B and the low estimate is $996.47M.
